Hydrolipoclasia
Hydrolipoclasia is a procedure made up of two others: mesotherapy and subsequent ultracavitation. It is used with the purported effects of reducing fat located in the waist, thighs or hips.
There is no evidence of the usefulness of this practice and the only existing publication in a scientific journal (Herreros 2009) is about its possible adverse effects, in particular, infection by atypical mycobacteria, as occurs in mesotherapy procedures.
Since the last update we have not found published data on its compatibility with breastfeeding.
The risk for breastfeeding or the infant depends on which product is injected under the skin, since its systemic absorption has been proven and, therefore, it could reach breastmilk.
See below the information of these related products:
- Cavitation (Very Low Risk)
- Mesotherapy (Low Risk probable)
Alternatives
- Cavitation (Very Low Risk)
- Cryolipolysis (Very Low Risk)
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Synonyms
- Ultrasonic Hydrolipoclasia
References
- Herreros FO, Velho PE, De Moraes AM, Cintra ML. Cutaneous atypical mycobacteriosis after ultrasound hydrolipoclasia treatment. Dermatol Surg. 2009Abstract Full text (link to original source) Full text (in our servers)